Research Overview
Dr. Cukor is an investigator on several studies related to PTSD and developing treatments for PTSD in diverse trauma populations. She is primary investigator on a study of an innovative treatment for burn patients that addresses the numerous psychiatric sequelae of burn injury, utilizing a manual she developed for the population. She is currently a co-investigator, primary clinician and project coordinator of a randomized controlled clinical trial comparing the use of D-Cycloserine versus placebo combined with virtual reality treatment for 9/11-related PTSD or combat-related PTSD in veterans of OIF/OEF. She is also a co-investigator on a multi-site RCT studying VR vs imaginal exposure and DCS vs placebo among OIF/OEF veterans. Dr. Cukor is a co-investigator on a study evaluating the longitudinal development of PTSD in burn patients with an evaluation of genetic risk factors for PTSD and the study of extinction utilizing neuroimaging. She was co-investigator on an STTR (R41) grant to develop and test a virtual environment for the treatment of PTSD and substance use resulting from the attacks of September 11, 2001. She was a co-investigator, primary clinician and project coordinator of an efficacy study evaluating the use of virtual reality in the treatment of PTSD following the World Trade Center attacks. Dr. Cukor was lead author on a recent invited review on emerging treatment for PTSD, has co-authored articles and book chapters, and been an invited speaker at Grand Rounds and conferences.